Spasmolytic therapy for primary dysmenorrhea

Abstract

Purpose of the study. Perform a brief review of the published works devoted to the evaluation of the effectiveness and safety of drotaverine hydrochloride in the treatment of abdominal cramping caused by primary dysmenorrhea, and an analysis of the use of obtained data in the clinical obstetrician-gynecologist practice.Materials and methods. The authors performed PubMed searches to find foreign and domestic articles using the keywords “dysmenorrhea”, “spasmolytic therapy”, “drotaverine”, “spasm”, “pain”. The analysis of the clinical studies showed the effectiveness of spasmolytic therapy of primary dysmenorrhea with drotaverin hydrochloride.Conclusion. Drotaverine hydrochloride can be recommended as an effective and safe first-choice drug to treat primary dysmenorrhea.